{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T14:28:38Z","timestamp":1793802518381,"version":"4.6.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,10]],"date-time":"2026-12-10T00:00:00Z","timestamp":1796860800000},"content-version":"am","delay-in-days":312,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32DA007292-31A1"],"award-info":[{"award-number":["T32DA007292-31A1"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Social Science & Medicine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.socscimed.2025.118868","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:13:13Z","timestamp":1764979993000},"page":"118868","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Structural contradictions in providing opioid use disorder care within the total institution of carceral facilities: Perspectives from patients and community service providers in Maryland"],"prefix":"10.1016","volume":"390","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9019-1597","authenticated-orcid":false,"given":"Ashley Q.","family":"Truong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0505-5679","authenticated-orcid":false,"given":"Victoria R.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0655-0583","authenticated-orcid":false,"given":"Kyle J.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Agus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1797-8593","authenticated-orcid":false,"given":"Sachini","family":"Bandara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omeid","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.socscimed.2025.118868_bib1","series-title":"The New Jim Crow: Mass Incarceration in the Age of Colorblindness","author":"Alexander","year":"2010"},{"issue":"12","key":"10.1016\/j.socscimed.2025.118868_bib3","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1111\/add.15565","article-title":"Methadone and buprenorphine treatment in United States jails and prisons: lessons from early adopters","volume":"116","author":"Bandara","year":"2021","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.socscimed.2025.118868_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40352-024-00311-7","article-title":"Implementation of carceral medicaid suspension and enrollment programs: perspectives of carceral and medicaid leaders","volume":"13","author":"Bandara","year":"2025","journal-title":"Health & Justice"},{"issue":"1","key":"10.1016\/j.socscimed.2025.118868_bib5","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/29767342241273417","article-title":"Racial differences in medications for opioid use disorder initiation in a carceral setting","volume":"46","author":"Berk","year":"2025","journal-title":"Subst Use Addctn J"},{"issue":"4","key":"10.1016\/j.socscimed.2025.118868_bib6","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/ADM.0000000000000942","article-title":"Injecting opioid use disorder treatment in jails and prisons: the potential of extended-release buprenorphine in the carceral setting","volume":"16","author":"Berk","year":"2022","journal-title":"J. Addict. Med."},{"issue":"1","key":"10.1016\/j.socscimed.2025.118868_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40352-025-00317-9","article-title":"Medication for opioid use disorder service delivery in carceral facilities: update and summary report","volume":"13","author":"Berk","year":"2025","journal-title":"Health & Justice"},{"issue":"1","key":"10.1016\/j.socscimed.2025.118868_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1940-0640-7-3","article-title":"Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors","volume":"7","author":"Binswanger","year":"2012","journal-title":"Addict Sci Clin Pract"},{"key":"10.1016\/j.socscimed.2025.118868_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.06.016","article-title":"The benefits and implementation challenges of the first state-wide comprehensive medication for addictions program in a unified jail and prison setting","volume":"205","author":"Brinkley-Rubinstein","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.socscimed.2025.118868_bib11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40352-025-00333-9","article-title":"Factors contributing to the expansion of medication for opioid use disorder (MOUD) within the new hampshire department of corrections (NHDOC)","volume":"13","author":"Clayman","year":"2025","journal-title":"Health & Justice"},{"issue":"3","key":"10.1016\/j.socscimed.2025.118868_bib13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/maq.12621","article-title":"Becoming institutionalized: incarceration as a chronic health condition","volume":"35","author":"Crane","year":"2021","journal-title":"Medical Anthropology Quarterly"},{"key":"10.1016\/j.socscimed.2025.118868_bib14","series-title":"Version 9.0.107. in Los Angeles, CA: Sociocultural Research Consultants","year":"2023"},{"key":"10.1016\/j.socscimed.2025.118868_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104252","article-title":"Diversion of medications to treat opioid use disorder: qualitative findings from formerly incarcerated adults in Massachusetts","volume":"122","author":"Evans","year":"2023","journal-title":"Int. J. Drug Pol."},{"key":"10.1016\/j.socscimed.2025.118868_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109254","article-title":"Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder","volume":"231","author":"Evans","year":"2022","journal-title":"Drug Alcohol Depend."},{"issue":"9","key":"10.1016\/j.socscimed.2025.118868_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.34704","article-title":"Factors associated with the availability of medications for opioid use disorder in US jails","volume":"7","author":"Flanagan Balawajder","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.socscimed.2025.118868_bib19","article-title":"Michigan department of corrections officer sentenced for smuggling drugs inside prison","author":"Foster","year":"2025","journal-title":"WILX"},{"issue":"9","key":"10.1016\/j.socscimed.2025.118868_bib20","first-page":"1408","article-title":"Are we there yet? Data saturation in qualitative research","volume":"20","author":"Fusch","year":"2015","journal-title":"Qual. Rep."},{"key":"10.1016\/j.socscimed.2025.118868_bib21","series-title":"Asylums","author":"Goffman","year":"1961"},{"key":"10.1016\/j.socscimed.2025.118868_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102768","article-title":"A scoping review of barriers and facilitators to implementation of medications for treatment of opioid use disorder within the criminal justice system","volume":"81","author":"Grella","year":"2020","journal-title":"Int. J. Drug Pol."},{"key":"10.1016\/j.socscimed.2025.118868_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108349","article-title":"Use of non\u2013prescribed buprenorphine in the criminal justice system: perspectives of individuals recently released from incarceration","volume":"127","author":"Gryczynski","year":"2021","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.socscimed.2025.118868_bib24","article-title":"Fatal and nonfatal opioid overdose risk following release from prison: a retrospective cohort study using linked administrative data","volume":"147","author":"Hartung","year":"2023","journal-title":"J Subst Use Addict Treat"},{"issue":"1","key":"10.1016\/j.socscimed.2025.118868_bib25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13722-023-00377-y","article-title":"\u201cJust fighting for my life to stay alive\u201d: a qualitative investigation of barriers and facilitators to community re-entry among people with opioid use disorder and incarceration histories","volume":"18","author":"Hoffman","year":"2023","journal-title":"Addiction Sci. Clin. Pract."},{"key":"10.1016\/j.socscimed.2025.118868_bib26","series-title":"People in Jail and Prison in 2020","author":"Kang-Brown","year":"2021"},{"key":"10.1016\/j.socscimed.2025.118868_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102978","article-title":"A systematic review of qualitative evidence on barriers to and facilitators of the implementation of opioid agonist treatment (OAT) programmes in prisons","volume":"87","author":"Komalasari","year":"2021","journal-title":"Int J Drug Policy"},{"issue":"5","key":"10.1016\/j.socscimed.2025.118868_bib28","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1377\/hlthaff.2024.01423","article-title":"State-mandated opioid use disorder treatment in Maryland jails helped patients recover despite gaps in care: article examines state-mandated opioid use disorder treatment for recently incarcerated people","volume":"44","author":"Kramer","year":"2025","journal-title":"Health Aff."},{"issue":"1","key":"10.1016\/j.socscimed.2025.118868_bib29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13722-022-00313-6","article-title":"Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative","volume":"17","author":"Krawczyk","year":"2022","journal-title":"Addiction Sci. Clin. Pract."},{"key":"10.1016\/j.socscimed.2025.118868_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2019.05.002","article-title":"Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: addressing a critical care gap","volume":"103","author":"Krawczyk","year":"2019","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.socscimed.2025.118868_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103786","article-title":"Has the treatment gap for opioid use disorder narrowed in the US?: a yearly assessment from 2010 to 2019\u201d","volume":"110","author":"Krawczyk","year":"2022","journal-title":"Int. J. Drug Pol."},{"issue":"3","key":"10.1016\/j.socscimed.2025.118868_bib32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.socscimed.2025.118868_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108851","article-title":"Use of long-acting injectable buprenorphine in the correctional setting","volume":"142","author":"Martin","year":"2022","journal-title":"J. Subst. Abuse Treat."},{"issue":"1","key":"10.1016\/j.socscimed.2025.118868_bib36","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40352-024-00280-x","article-title":"Facilitators and barriers to adopting or expanding medications for opioid use disorder provision in rural Colorado jails: a qualitative analysis","volume":"12","author":"McNeely","year":"2024","journal-title":"Health & Justice"},{"key":"10.1016\/j.socscimed.2025.118868_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108267","article-title":"Exploring nonprescribed use of buprenorphine in the criminal justice system through qualitative interviews among individuals recently released from incarceration","volume":"123","author":"Monico","year":"2021","journal-title":"J. Subst. Abuse Treat."},{"issue":"1","key":"10.1016\/j.socscimed.2025.118868_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/0966369X.2012.759906","article-title":"Leaving behind the \u2018total institution\u2019? Teeth, transcarceral spaces and (re) inscription of the formerly incarcerated body","volume":"21","author":"Moran","year":"2014","journal-title":"Gend. Place Cult."},{"issue":"5","key":"10.1016\/j.socscimed.2025.118868_bib39","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/00952990.2024.2401980","article-title":"Leveraging extended-release buprenorphine to improve care for opioid use disorder in the criminal-legal system","volume":"50","author":"Murphy","year":"2024","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.socscimed.2025.118868_bib40","series-title":"Medications for Opioid Use Disorder save Lives","year":"2019"},{"key":"10.1016\/j.socscimed.2025.118868_bib41","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s40429-019-00283-x","article-title":"Medications for opioid use disorder among incarcerated individuals: a review of the literature and focus on patient preference","volume":"6","author":"Puglisi","year":"2019","journal-title":"Current Addiction Reports"},{"issue":"9","key":"10.1016\/j.socscimed.2025.118868_bib42","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis","volume":"78","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.socscimed.2025.118868_bib43","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40352-024-00291-8","article-title":"Linkage facilitation for opioid use disorder in criminal legal system contexts: a primer for researchers, clinicians, and legal practitioners","volume":"12","author":"Satcher","year":"2024","journal-title":"Health & Justice"},{"issue":"4","key":"10.1016\/j.socscimed.2025.118868_bib44","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s11135-017-0574-8","article-title":"Saturation in qualitative research: exploring its conceptualization and operationalization","volume":"52","author":"Saunders","year":"2018","journal-title":"Qual. Quantity"},{"key":"10.1016\/j.socscimed.2025.118868_bib45","author":"Sawyer"},{"key":"10.1016\/j.socscimed.2025.118868_bib53","article-title":"Mass incarceration: The whole pie 2025","author":"Sawyer","year":"2025","journal-title":"Prison Pol Initiative"},{"issue":"6","key":"10.1016\/j.socscimed.2025.118868_bib54","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s11606-022-07812-x","article-title":"Availability of medications for opioid use disorder in US jails","volume":"38","author":"Sufrin","year":"2023","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.socscimed.2025.118868_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ssmqr.2024.100453","article-title":"\u201cThey talked to me like I was dirt under their feet:\u201d treatment and withdrawal experiences of incarcerated pregnant people with opioid use disorder in four US states","volume":"6","author":"Sufrin","year":"2024","journal-title":"SSM-Qualitative Research in Health"},{"issue":"6","key":"10.1016\/j.socscimed.2025.118868_bib47","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int. J. Qual. Health Care"},{"issue":"1","key":"10.1016\/j.socscimed.2025.118868_bib48","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1080\/08897077.2022.2060448","article-title":"Medications for opioid use disorder in state prisons: perspectives of formerly incarcerated persons","volume":"43","author":"Treitler","year":"2022","journal-title":"Subst Abus"},{"issue":"2","key":"10.1016\/j.socscimed.2025.118868_bib50","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.socscimed.2025.118868_bib51","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0558","article-title":"Health, polysubstance use, and criminal justice involvement among adults with varying levels of opioid use","volume":"1","author":"Winkelman","year":"2018","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.socscimed.2025.118868_bib52","article-title":"Less than half of Maryland jails comply with opioid-addiction treatment law meant to save lives","author":"Zhu","year":"2023","journal-title":"The Baltimore Banner"}],"container-title":["Social Science & Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0277953625011992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0277953625011992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:51:07Z","timestamp":1793800267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0277953625011992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":47,"alternative-id":["S0277953625011992"],"URL":"https:\/\/doi.org\/10.1016\/j.socscimed.2025.118868","relation":{},"ISSN":["0277-9536"],"issn-type":[{"value":"0277-9536","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural contradictions in providing opioid use disorder care within the total institution of carceral facilities: Perspectives from patients and community service providers in Maryland","name":"articletitle","label":"Article Title"},{"value":"Social Science & Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.socscimed.2025.118868","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118868"}}